BMS - EGYPTIAN MATURE PRODUCTS BUSINESS
BMS - Egyptian Mature Products Business provides pharmaceutical products.
Similar Organizations
DHG Pharma
DHG Pharma produces and trades in pharmaceutical products.
Diagnostic Green
Diagnostic Green provides pharmaceutical products.
More informations about "BMS - Egyptian Mature Products Business"
BMS - Egyptian Mature Products Business: Drug pipelines, Patents ...
Explore BMS - Egyptian Mature Products Business with its drug pipeline, therapeutic area, technology platform, 2 news. Data. Feature. Plans. Sign Up for Free. Request Demo. Sign Up for Free. Last update 01 Jun 2023. BMS - Egyptian Mature Products Business. Private Company. Private Company. Last update 01 Jun 2023. Overview. Pipeline.See details»
GSK Acquires Bristol-Myers Egypt Unit For $210M
Oct 16, 2008 GlaxoSmithKline plc (GSK) recently announced that it will acquire the Egyptian mature products business of Bristol Myers Squibb (BMS), for $210 (£125) million, in a move to accelerate sales growth and further extend its pharmaceutical portfolio in emerging markets.See details»
GSK to drive growth in emerging markets with acquisition of UCB …
This acquisition follows the agreement GSK announced with South African-based pharmaceuticals company Aspen in July 2008, which significantly extended GSK’s pharmaceuticals portfolio in emerging markets, the acquisition of the Egyptian mature products business of Bristol Myers Squibb (BMS) in October 2008 and the acquisition of BMS Pakistan …See details»
GSKâ s Emerging Markets strategy advances with acquisition in …
Oct 20, 2008 GlaxoSmithKline plc (GSK) has announced that it will acquire the Egyptian mature products business of Bristol Myers Squibb (BMS), for $210 (£125) million, in a move to accelerate sales growth and further extend its pharmaceutical portfolio in emerging markets.See details»
Bristol-Myers Squibb Co. /Egyptian Mature Products Bus/
Explore Bristol-Myers Squibb Co. /Egyptian Mature Products Bus/ with its drug pipeline, therapeutic area, technology platform, .See details»
GlaxoSmithKline acquires BMS - Egyptian Mature Products …
GlaxoSmithKline acquires BMS - Egyptian Mature Products Business on 2008-10-16 for $215859267. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. ... Overview. Edit Overview Section. Acquired Organization: BMS - Egyptian Mature Products Business BMS - Egyptian Mature Products Business provides pharmaceutical ...See details»
GSK’s Emerging Markets strategy advances with acquisition in Egypt
Oct 15, 2008 GlaxoSmithKline plc (GSK) today announced that it will acquire the Egyptian mature products business of Bristol Myers Squibb (BMS), for $210 (£125) million, in a move to accelerate sales growth ...See details»
BMS - Egyptian Mature Products Business - Crunchbase
Organization. BMS - Egyptian Mature Products Business . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies Section. Companies like BMS - Egyptian Mature Products Business include DHG Pharma, Diagnostic Green, and Egyptian Company for Pharmaceuticals & Chemical Industries.See details»
GSK confirms emerging markets strategy, buying B-MS' Egyptian …
Oct 27, 2008 Confirming UK drug giant GlaxoSmithKline's intentions to diversify into new sectors under its new chief executive Andrew Witty (Marketletter August 4), the firm says that it will acquire the Egyptian mature products business of US major Bristol-Myers Squibb for $210.0 million, in a move to accelerate sales growth and further extend its pharmaceutical portfolio in …See details»
Glaxo expands in Egypt with $210 mln acquisition | Reuters
Oct 15, 2008 GlaxoSmithKline Plc is buying the Egyptian mature products business of Bristol-Myers Squibb Co for $210 million, to extend the British drug company's recent expansion into emerging markets.See details»
GlaxoSmithKlines acquires Bristol-Myers Squibb’s Egyptian mature ...
LONDON GlaxoSmithKline has acquired the Egyptian mature products business of Bristol-Myers Squibb, the British drug maker announced Wednesday.. GSK said the acquisition, worth $210 million, is a ...See details»
Oscar Delgado – General Manager MEA, Bristol Myers Squibb
Sep 12, 2022 Our objective is to ensure that Bristol Myers Squibb is able to deliver innovation by working closely with the main stakeholders including different health insurances, the UPA (Egyptian Authority for Unified Procurement, Medical Supply, and Technology Management) the EDA (Egyptian Drug Authority), and any public-private opportunities for collaboration.See details»
GSK’s Emerging Markets strategy advances with acquisition in Egypt
Oct 20, 2008 PharmaNews.eu - Breaking European Pharmaceutical News. Details GlaxoSmithKline 20 October 2008 GlaxoSmithKline plc (GSK) has announced that it will acquire the Egyptian mature products business of Bristol Myers Squibb (BMS), for $210 (£125) million, in a move to accelerate sales growth and further extend its pharmaceutical portfolio in emerging …See details»
Acquisition of Egyptian Mature Products Business
Share Prices. Share Prices. Financial Diary; Commodities; Broker Ratings; UK Industry SectorsSee details»
GSK to buy Bristol-Myers Eqypt operations | Fierce Pharma
Oct 15, 2008 GlaxoSmithKline announced today that it will spend $210 million to purchase Bristol-Myers Squibb's portfolio of drugs in Egypt, as well as the BMS plant near Cairo. GSK will acquire 20 olderSee details»
Glaxo expands in Egypt with $210 mln acquisition | Reuters
LONDON, Oct 15 (Reuters) - GlaxoSmithKline Plc is buying the Egyptian mature products business of Bristol-Myers Squibb Co for $210 million, to extend the British drug company's recent expansion ...See details»
BMS EGYPT Company Profile | Cairo, Cairo, Egypt | Competitors ...
Find company research, competitor information, contact details & financial data for BMS EGYPT of Cairo, Cairo. Get the latest business insights from Dun & Bradstreet. ... Chemical and Allied Products Merchant Wholesalers ... Get full access to view your D&B business credit file now for just $39/month! View D&B Scores & Ratings. Discover.See details»
Our partnerships - Bristol Myers Squibb
We have a rich heritage in business development. We have a rich heritage in partnering with a long history of successful scientific and commercial collaborations. Partnering has been an integral part of our evolution to become a leading biopharma company – it’s part of our DNA.See details»
Org Chart Bristol-Myers Squibb - The Official Board
Www.bms.com. has 195 executives and 23 subsidiaries +1 212 546 4000; Add an executive. Bristol-Myers Squibb (BMY) News ... Cell Therapy Organization. L... Move. Cell Therapy Brand & Strategy. B... Move. RayzeBio & Mirati. B... President @ RayzeBio. Move. Chief of Staff. ... Fuel your business (and LLM) Frequently asked questions; Executives ...See details»